Back to home
Together Against HIV
Johnson & Johnson has been dedicated to the fight against HIV for 25 years. And now we’re working with our partners to develop the first global vaccine for HIV.

With more progress to come, we’re committed to turning the tide of the HIV pandemic.
Video-02.png
An estimated 37 million people are currently living with HIV worldwide and 1.8 million are newly infected each year, many of whom lack access to the treatment and resources they need. In 2017, Johnson & Jonson released the first single-pill treatment for HIV-1, which reduces pill burden and has improved outcomes for people living with HIV. Outside of medicine, we support numerous advocacy organizations like the Black AIDS Institute and Mothers2Mothers to educate communities about HIV prevention and help grant access to crucial treatment for patients in the most affected areas. From scientists developing new treatments to frontline health workers supporting at-risk communities J&J is united to strive towards an HIV-free world.

Read more about our work in HIV/AIDS on jnj.com
See How We're Helping
Watch video

Johnson & Johnson has been dedicated to the fight against HIV for 25 years. And now we’re working with our partners to develop the first global vaccine for HIV.

With more progress to come, we’re committed to turning the tide of the HIV pandemic.
Watch video

Throughout history, nurses have brought innovation to patient care that has profoundly changed human health. And since 1897, Johnson & Johnson has been proud to support nurses through employment, platforms, partnerships, training and millions in scholarships and grants. Because nurses change lives. And that changes everything. #changinghumanhealth #nurseschangelives
Watch video

Nothing is more important to Johnson & Johnson than the health of the world. #changinghumanhealth
Meet the Scientist Who's Sharing the Spotlight With Celebs at the Global Citizen Festival

It isn't just music superstars who attend the annual event in Central Park. Johnson & Johnson 's Chief Scientific Officer, Dr. Paul Stoffels, is on the lineup, too. He shares his personal story of why he's so dedicated to global public health—and how the company is working to prevent HIV infections through an investigational vaccine.
Johnson & Johnson is committed to creating a world where a healthy mind, body and environment is within reach for everyone, everywhere.

We’re proud to partner with Global Citizen to further this commitment and help bring good health to all humanity. In partnership, we’ll create a healthier and more equitable future. Because health changes everything.
Screen Shot 2018-09-09 at 18.29.14.png
90.png
4 Amazing Men and Women at the Forefront of HIV Work
As the International AIDS Society Conference on HIV Science kicks off, we’re spotlighting researchers who've dedicated their life's work to tackling the epidemic in groundbreaking ways.
Follow #MakeHIVHistory
Be a part of the conversation
Johnson & Johnson
@JNJCares
Finding a preventive vaccine is one of the biggest scientific challenges in the 35-year quest to end the #HIV pandemic. We are proud to be working with leading #GlobalHealth advocates to #MakeHIVHistory : https://goo.gl/upBNMg #AIDS2018 #JNJ
Johnson & Johnson
@JNJCares
We’re closer than ever to an #HIV vaccine, and #JNJ researcher Hanneke Schuitmaker, Ph.D. is helping #makeHIVhistory through her research and dedication to saving lives: https://goo.gl/NcmbFt
Johnson & Johnson
@JNJCares
Together with @GlblCtzn , we’re set to continue our mission to change the trajectory of #HealthforHumanity . Join us in NYC on Sept. 29th at this year’s #GlobalCitizen Festival to learn about our work and see @theweeknd , @JanetJackson and more: http://glblctzn.me/gcfnyc2018
More Ways to Take Action
This site uses cookies as described in our Cookie Policy . Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
i